Life-spanning trajectories and critical events that influence hospitalization and death.
Arcellx won the battle of BCMA CAR-T therapies
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I just returned